Day: March 24, 2026

us corporate news

Talphera, Inc. (Formerly AcelRx) 2025 Annual Report: Business Overview, Key Risks, and Regulatory Challenges in Specialty Pharmaceuticals

Minichart

March 24, 2026

Talphera, Inc. 2025 Annual Report: Investor Analysis & Highl...

Continue Reading 0

us corporate news

Semtech Corporation 2026 Annual Report: Financials, Risk Factors, and Corporate Governance Overview

Minichart

March 24, 2026

Semtech Corporation 2026 Annual Report: Key Insights for Inv...

Continue Reading 0

us corporate news

Yunhong Green CTI Ltd. 2025 Annual Report: Business Overview, Strategies, Product Lines, and Financial Results

Minichart

March 24, 2026

Yunhong Green CTI Ltd. 2025 Annual Report: Key Investor High...

Continue Reading 0

us corporate news

ParkerVision, Inc. 2025 Annual Report: Patent Enforcement, Licensing, and Cybersecurity Risk Management

Minichart

March 24, 2026

ParkerVision 2025 Annual Report: Key Details for Investors ...

Continue Reading 0

us corporate news

Bionano Genomics 2025 Annual Report Highlights: Optical Genome Mapping, Market Expansion, and Risk Factors 57596054

Minichart

March 24, 2026

Bionano Genomics 2025 Annual Report - Investor Highlights ...

Continue Reading 0

us corporate news

Context Therapeutics 2025 Annual Report: Business Strategy, Risk Factors, Clinical Pipeline, and Regulatory Insights

Minichart

March 24, 2026

Context Therapeutics Inc. 2025 Annual Report Analysis In...

Continue Reading 0

us corporate news

SolarEdge Technologies 2025 10-K/A: Smart Energy Solutions, Business Overview, and Forward-Looking Risk Factors

Minichart

March 24, 2026

SolarEdge Technologies, Inc. 2025 Annual Report - Key Highli...

Continue Reading 0

us corporate news

Greenland Technologies Holding Corporation: Electric Industrial Equipment, Market Trends, and Competitive Strengths (2025)

Minichart

March 24, 2026

Greenland Technologies Holding Corporation 2025 10-K Report ...

Continue Reading 0

us corporate news

Aardvark Therapeutics, Inc. – Clinical-Stage Biopharma Advancing TAS2R Small-Molecule Therapies for Obesity and Metabolic Diseases

Minichart

March 24, 2026

Aardvark Therapeutics 2025 Annual Report – Key Highlights fo...

Continue Reading 0

us corporate news

SilverBox Corp V 2025 Annual Report: Business Strategy, Competitive Advantages, and SPAC Opportunities

Minichart

March 24, 2026

SilverBox Corp V 2025 Annual Report – Key Points and Investo...

Continue Reading 0